• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用阿托伐他汀后高密度脂蛋白亚组分(HDL2和HDL3)的化学修饰

Chemical modification of high density lipoprotein subfractions - HDL2 and HDL3 - after use of atorvastatin.

作者信息

de Souza Zago Vanessa Helena, Tanus-Santos José Eduardo, Gardin Danelon Mirian Regina, Parra Eliane Soler, Alexandre Fernanda, Vieira Isabela Calanca, Panzoldo Natália Baratella, D'Alexandri Fábio Luís, Rocha Quintão Eder Carlos, de Faria Eliana Cotta

出版信息

Int J Clin Pharmacol Ther. 2014 Apr;52(4):277-83. doi: 10.5414/CP201742.

DOI:10.5414/CP201742
PMID:24548977
Abstract

Regardless of its effect on the concentrations of serum cholesterol, statins exert pleiotropic effects, including the regulation of endothelial function, reduced oxidative stress and inflammation, as well as a slight improvement in the concentrations of high density lipoprotein (HDL). However, its role on the composition of HDL is not yet established. The aim of this study was to evaluate the composition of HDL subfractions, HDLsub>2 and HDL3, after 14 days of placebo and atorvastatin (10 mg/day) use in 30 asymptomatic volunteers. The serum parameters and the HDL subfractions compositions were determined using radiometric, nephelometric and biochemical enzymatic methods. We observed significant reductions of total cholesterol, low density lipoprotein (LDL) and apolipoprotein B-100 by 28%, 40% and 38%, respectively. The analyses of chemical composition of the subfractions revealed a lower lipid protein ratio in HDL2, suggesting enrichment in proteins, and also lower in HDL3, probably by an increase in the number of particles. Several mechanisms can be suggested for the effects observed after the use of atorvastatin, such as a possible action on the reverse cholesterol transport (decreased activity of hepatic lipase and increased phospholipid transfer protein, PLTP), which would explain the enrichment of HDL. The results suggest that statin use may be relevant in the primary prevention of atherosclerosis not only by its lowering effect on LDLcholesterol and its anti-inflammatory effect but also by beneficial changes in HDL subfractions.

摘要

无论他汀类药物对血清胆固醇浓度有何影响,它们都具有多效性作用,包括调节内皮功能、减轻氧化应激和炎症,以及使高密度脂蛋白(HDL)浓度略有升高。然而,其对HDL组成的作用尚未明确。本研究的目的是评估30名无症状志愿者在服用安慰剂和阿托伐他汀(10毫克/天)14天后HDL亚组分HDL2和HDL3的组成。使用放射测量法、散射比浊法和生化酶法测定血清参数和HDL亚组分组成。我们观察到总胆固醇、低密度脂蛋白(LDL)和载脂蛋白B - 100分别显著降低了28%、40%和38%。亚组分化学成分分析显示,HDL2中的脂蛋白比率较低,表明蛋白质含量增加,HDL3中的脂蛋白比率也较低,可能是由于颗粒数量增加。对于使用阿托伐他汀后观察到的效果,可以提出几种机制,例如可能对逆向胆固醇转运有作用(肝脂酶活性降低和磷脂转运蛋白PLTP增加),这可以解释HDL的富集。结果表明,他汀类药物的使用可能不仅通过其降低LDL胆固醇的作用和抗炎作用,而且通过HDL亚组分的有益变化,在动脉粥样硬化的一级预防中具有重要意义。

相似文献

1
Chemical modification of high density lipoprotein subfractions - HDL2 and HDL3 - after use of atorvastatin.使用阿托伐他汀后高密度脂蛋白亚组分(HDL2和HDL3)的化学修饰
Int J Clin Pharmacol Ther. 2014 Apr;52(4):277-83. doi: 10.5414/CP201742.
2
Atorvastatin effect on the distribution of high-density lipoprotein subfractions and human paraoxonase activity.阿托伐他汀对高密度脂蛋白亚组分分布及人对氧磷酶活性的影响。
Transl Res. 2009 Apr;153(4):190-8. doi: 10.1016/j.trsl.2009.01.007. Epub 2009 Feb 14.
3
Influence of atorvastatin and carboxymethylated glucan on the serum lipoprotein profile and MMP activity of mice with lipemia induced by poloxamer 407.阿托伐他汀和羧甲基葡聚糖对聚氧乙烯 407 诱导的脂血症小鼠血清脂蛋白谱和 MMP 活性的影响。
Can J Physiol Pharmacol. 2012 Feb;90(2):141-53. doi: 10.1139/y11-118. Epub 2012 Feb 9.
4
Atorvastatin affects low density lipoprotein and non-high density lipoprotein cholesterol relations with apolipoprotein B in type 2 diabetes mellitus: modification by triglycerides and cholesteryl ester transfer protein.阿托伐他汀对2型糖尿病患者低密度脂蛋白及非高密度脂蛋白胆固醇与载脂蛋白B关系的影响:甘油三酯和胆固醇酯转运蛋白的修饰作用
Expert Opin Ther Targets. 2009 Jul;13(7):743-51. doi: 10.1517/14728220903023866.
5
Impact of short-term administration of high-density lipoproteins and atorvastatin on atherosclerosis in rabbits.短期给予高密度脂蛋白和阿托伐他汀对兔动脉粥样硬化的影响。
Arterioscler Thromb Vasc Biol. 2005 Nov;25(11):2416-21. doi: 10.1161/01.ATV.0000184760.95957.d6. Epub 2005 Sep 1.
6
Effects of prescription omega-3-acid ethyl esters, coadministered with atorvastatin, on circulating levels of lipoprotein particles, apolipoprotein CIII, and lipoprotein-associated phospholipase A2 mass in men and women with mixed dyslipidemia.ω-3 酸乙酯处方药与阿托伐他汀联合应用对混合性血脂异常患者循环脂蛋白颗粒、载脂蛋白 CIII 和脂蛋白相关磷脂酶 A2 质量的影响。
J Clin Lipidol. 2011 Nov-Dec;5(6):483-92. doi: 10.1016/j.jacl.2011.09.001. Epub 2011 Sep 13.
7
Resveratrol protects against atherosclerosis, but does not add to the antiatherogenic effect of atorvastatin, in APOE*3-Leiden.CETP mice.白藜芦醇可预防动脉粥样硬化,但不能增强 APOE*3-Leiden.CETP 小鼠阿托伐他汀的抗动脉粥样硬化作用。
J Nutr Biochem. 2013 Aug;24(8):1423-30. doi: 10.1016/j.jnutbio.2012.11.009. Epub 2013 Jan 18.
8
Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.烟浪丁(季戊四醇四烟酸酯)对血浆脂蛋白浓度的影响:低高密度脂蛋白血症中高密度脂蛋白(HDL)胆固醇及HDL胆固醇/低密度脂蛋白胆固醇比值的升高
Artery. 1982;10(4):266-85.
9
Up-regulation of hepatic low-density lipoprotein receptor-related protein 1: a possible novel mechanism of antiatherogenic activity of hydroxymethylglutaryl-coenzyme A reductase inhibitor Atorvastatin and hepatic LRP1 expression.肝低密度脂蛋白受体相关蛋白 1 的上调:羟甲基戊二酰辅酶 A 还原酶抑制剂阿托伐他汀具有抗动脉粥样硬化活性的可能新机制及肝 LRP1 表达。
Metabolism. 2011 Jul;60(7):930-40. doi: 10.1016/j.metabol.2010.08.013. Epub 2010 Oct 15.
10
Pharmacodynamics and pharmacokinetic-pharmacodynamic relationships of atorvastatin, an HMG-CoA reductase inhibitor.阿托伐他汀(一种HMG-CoA还原酶抑制剂)的药效学及药代动力学-药效学关系
J Clin Pharmacol. 2000 Jun;40(6):616-23.

引用本文的文献

1
Analysis of pathogenesis and drug treatment of chronic obstructive pulmonary disease complicated with cardiovascular disease.慢性阻塞性肺疾病合并心血管疾病的发病机制及药物治疗分析
Front Med (Lausanne). 2022 Nov 4;9:979959. doi: 10.3389/fmed.2022.979959. eCollection 2022.
2
No Independent Influence of Statins on the Chronic Obstructive Pulmonary Disease Exacerbation Rate: A Cohort Observation Study Over 10 Years.他汀类药物对慢性阻塞性肺疾病急性加重率无独立影响:一项为期10年的队列观察研究
Int J Gen Med. 2021 Jun 28;14:2883-2892. doi: 10.2147/IJGM.S309647. eCollection 2021.
3
Accurate Quantification of Disease Markers in Human Serum Using Iron Oxide Nanoparticle-linked Immunosorbent Assay.
利用氧化铁纳米粒子连接免疫吸附测定法对人血清中疾病标志物进行精确定量。
Theranostics. 2016 Jun 15;6(9):1353-61. doi: 10.7150/thno.16093. eCollection 2016.